Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Adipotide 0.1–0.43 mg/kg AOD-9604 250–500 mcg Frequency Once daily Administration Subcutaneous injection Cycle Length 4-6 weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) Gradual (3-4 weeks) Evidence Level Strong preclinical (extensive animal studi

This comparison does not assign a generated winner or score.

  • Dose Range
  • Adipotide
  • 0.1–0.43 mg/kg
  • AOD-9604
  • 250–500 mcg
  • Frequency
  • Once daily
  • Administration
  • Subcutaneous injection
  • Cycle Length
  • 4-6 weeks
  • 8-12 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Gradual (3-4 weeks)
  • Evidence Level
  • Strong preclinical (extensive animal studies)
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material

Comparison

adipotide vs aod 9604

adipotide vs aod 9604 Adipotide vs AOD 9604: A Comprehensive Research Peptide Comparison for 2025 The world of research peptides continues to evolve rapidly, with scientists explo…

View details →
Comparison

Mechanism of Action Comparison

The fundamental difference between these peptides lies in their cellular targets and mechanisms. Adipotide functions as a vascular-targeting agent, specifically affecting blood su…

View details →